NCT04259125 (NSR-RISE) is a clinical trial of Blood draw in Neonatal Seizure, sponsored by University of California, San Francisco.

Who is sponsoring NCT04259125?

NCT04259125 is sponsored by University of California, San Francisco.

What drugs are being tested in NCT04259125?

Interventions in NCT04259125: Blood draw, Survey.

What condition does NCT04259125 study?

NCT04259125 studies Neonatal Seizure, Epilepsy, Seizures, Inflammatory Response.

Is NCT04259125 still recruiting?

NCT04259125 is currently completed. Last updated 26 January 2026.

Last reviewed 2026-01-26 · How we verify

NCT04259125: NSR-RISE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Role of Inflammation in Neonatal Epileptogenesis

Completed Last updated 26 January 2026

What this trial tests

trial testing Blood draw in Neonatal Seizure in 72 participants. Completed in 1 December 2025.

Timeline

15 December 2018

Primary endpoint
1 November 2024

1 December 2025

Quick facts

Lead sponsor	University of California, San Francisco
Status	Completed
Study type	OBSERVATIONAL
Enrollment	72
Start date	15 December 2018
Primary completion	1 November 2024
Estimated completion	1 December 2025
Sites	4 locations across United States

Drugs / interventions tested

Blood draw — full drug profile →
Survey

Conditions studied

Neonatal Seizure — all drugs for Neonatal Seizure →
Epilepsy — all drugs for Epilepsy →
Seizures — all drugs for Seizures →
Inflammatory Response — all drugs for Inflammatory Response →

Sponsor

University of California, San Francisco

Who can join

Adults 1 Day to 4 Days, any sex, with Neonatal Seizure or Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study evaluate the relationship between inflammation and epilepsy in neonates with seizures after birth.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Trials of Non-Coding RNAs as Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries.
Wang H, Wang Q, Xiao X, Luo X, et al · · 2023 · PMID 36443964 · DOI 10.2174/1570159x21666221128090025

Verify or expand the search:

Other trials of Blood draw

Trials testing the same drug.

NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
NCT07252622 — Progesterone Levels and Frozen Embryo Transfer Outcomes · not yet recruiting
NCT07382076 — Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population · active not recruiting
NCT06011824 — A Study of Effect of Megakaryocytes and Platelets in Breast Cancer · completed
NCT05912400 — Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1 · completed

Other recruiting trials for Neonatal Seizure

Currently open trials in the same condition.

NCT05610085 — A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures · Phase 2 · recruiting
NCT05361070 — Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy · active not recruiting
NCT04831242 — Monitoring Key Activity and Physiology of Neonates in Intensive Care · recruiting

Other University of California, San Francisco trials

Trials by the same sponsor.

NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04259125 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 26 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04259125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing